Self-Assembly of Recombinant Prion Protein of 106 Residues

DOI Web Site 1 Citations
  • Ilia V. Baskakov
    Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
  • Claus Aagaard
    Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
  • Ingrid Mehlhorn
    Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
  • Holger Wille
    Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
  • Darlene Groth
    Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
  • Michael A. Baldwin
    Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
  • Stanley B. Prusiner
    Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143
  • Fred E. Cohen
    Institute for Neurodegenerative Diseases, Department of Neurology, Department of Biochemistry and Biophysics, Department of Cellular and Molecular Pharmacology, Department of Medicine, and Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143

Journal

  • Biochemistry

    Biochemistry 39 (10), 2792-2804, 2000-02-19

    American Chemical Society (ACS)

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top